Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-25T06:35:45.488Z Has data issue: false hasContentIssue false

TAK-242 Attenuates Crush Injury Induced Acute Kidney Injury through Inhibiting TLR4/NF-κB Signaling Pathways in Rats

Published online by Cambridge University Press:  24 September 2020

Jinxiang Wang
Affiliation:
Emergency Department, Tianjin Medical University General Hospital, Tianjin, China
Zhiguo Chen
Affiliation:
Emergency Department, Tianjin Medical University General Hospital, Tianjin, China
Shike Hou*
Affiliation:
Institute of Disaster Medicine, Tianjin University, Tianjin, China
Ziquan Liu
Affiliation:
Institute of Disaster Medicine, Tianjin University, Tianjin, China
Qi Lv
Affiliation:
Institute of Disaster Medicine, Tianjin University, Tianjin, China
*
Correspondence: Shike Hou, MPH, Institute of Disaster Medicine, Tianjin University, No. 92 Weijin Road, Nankai District, Tianjin, 300000, China, E-mail: [email protected]

Abstract

Background:

To investigate if toll-like receptor (TLR) 4/nuclear factor-kappa B (NF-κB) signaling pathways mediated crush injury induced acute kidney injury (AKI) in rats, and if TAK-242 (a specific inhibitor of TLR4) attenuates the injury through inhibiting the signaling pathways.

Methods:

This study was divided into two parts: (1) Establish the crush injury model: 50 rats were randomly divided into control group and four crush injury groups (n = 10/group). Crush injury groups were given 3kg pressure for eight hours and were sacrificed at the time points of 0h, 6h, 12h, and 24h after relieving pressure. And (2) Select the most obvious injury group (12h group) for drug intervention group. Thirty rats were randomly divided into control group, 12h group, and 12h+TAK-242 group (n = 10/group). Two parts detection were as follows: pathological changes of kidney tissues were observed in Haematoxylin and Eosin (HE) staining. Serum creatinine, blood urea nitrogen (BUN), myoglobin (Mb), and blood potassium were examined by automatic biochemical analysis instrument. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured by enzyme-linked immunosorbent assay (ELISA). The TLR4 messenger ribonucleic acid (mRNA), TLR4, and P65 were detected by real-time polymerase chain reaction (PCR), western blot, immunohistochemistry staining.

Results:

Compared with the control group, kidney tissues were damaged in crush injury groups, and most obvious in the 12h group. The level of serum creatinine, BUN, Mb, blood potassium, IL-6, TNF-α, and TLR4mRNA were increased in the crush injury groups and significantly increased in the 12h group (P <.05). The TLR4 and P65 were significantly increased in the 12h group (P <.05). Compared with the 12h group, kidney tissue damage was significantly reduced in the TAK-242 group (P <.05). The level of serum creatinine, BUN, Mb, blood potassium, IL-6, TNF-α, TLR4mRNA, TLR4, and P65 in the TAK-242 group were significantly reduced (P <.05).

Conclusion:

The present findings conclude that TLR4/NF-κB signaling pathways mediated crush injury induced AKI in rats, and TAK-242 attenuates the injury through inhibiting the signaling pathways.

Type
Original Research
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of the World Association for Disaster and Emergency Medicine

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Note: Drs. Wang and Chen contributed equally to this article.

References

Sever, MS, Vanholder, R. Management of crush victims in mass disasters: highlights from recently published recommendations. Clin J Am SocNephrol. 2013;8(2):328-335.CrossRefGoogle ScholarPubMed
Bartels, SA, VanRooyen, MJ. Medical complications associated with earthquakes. Lancet. 2012;379(9817):748-757.CrossRefGoogle ScholarPubMed
Peiris, D. A historical perspective on crush syndrome: the clinical application of its pathogenesis, established by the study of wartime crush injuries. J Clin Pathol. 2017;70(4):277-281.CrossRefGoogle Scholar
Li, L, Kang, J, Lei, W. Role of toll-like receptor 4 in inflammation-induced preterm delivery. Mol Hum Reprod. 2010;16(4):267.CrossRefGoogle ScholarPubMed
Teo, JDW, Macary, PA, Tan, KSW. Pleiotropic effects of Blastocystis spp. Subtypes 4 and 7 on ligand specific toll-like receptor signaling and NF-kappaB activation in a human monocyte cell line. PLoS One. 2014;9(2):e89036.CrossRefGoogle Scholar
Sun, J, Shi, S, Wang, Q, Yu, K, Wang, R. Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFkappaB in a dog sepsis model. Int J Clin Exp Pathol. 2015;8(2):1555-1564.Google Scholar
Wu, Y, Liu, Y, Huang, H, et al. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-kappaB pathway. Mediators Inflamm. 2013;2013:562154.Google ScholarPubMed
Rodrigues, CE, Sanches, TR, Volpini, RA, et al. Effects of continuous erythropoietin receptor activator in sepsis-induced AKI and multiorgan dysfunction. PLoS One. 2012;7(1):e29893.10.1371/journal.pone.0029893CrossRefGoogle Scholar
Shibata, A, Sugiura, K, Furuta, y, et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J Autoimmun. 2017;80:28-38.10.1016/j.jaut.2017.01.007CrossRefGoogle ScholarPubMed
Krock, E, Millecamps, M, Currie, JB, et al. Low back pain and disc degeneration are decreased following chronic toll-like receptor 4 inhibition in a mouse model. Osteoarthritis Cartilage. 2018;26(9):1236-1246.CrossRefGoogle ScholarPubMed
Gárate, I, García-Bueno, B, Muñoz Madrigal, JL, et al. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation. 2014;11:8.Google ScholarPubMed
Scapellato, S, Maria, S, Castorina, G, et al. Crush syndrome. Minerva Chir. 2007;62(4):285-292.Google ScholarPubMed
Gonzalez, D. Crush syndrome. Crit Care Med. 2005;33(1S):S34-41.Google ScholarPubMed
Oda, J, Tanaka, H, Yoshioka, T, et al. Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma. 1997;42(3):470-475.CrossRefGoogle ScholarPubMed
Chen, R, Alvero, AB, Silasi, DA, et al. Cancers take their toll: the function and regulation of Toll-like receptors in cancer cells. Oncogene. 2008;27(2):225-233.Google ScholarPubMed
Chen, K, Huang, J, Gong, W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007;7(10):1271-1285.CrossRefGoogle Scholar
Ostuni, R, Zanoni, I, Granucci, F. Deciphering the complexity of Toll-like receptor signaling. Cell Mol Life Sci. 2010;67(24):4109-4134.CrossRefGoogle ScholarPubMed
Yang, J, Amiri, KI, Burke, JR, et al. BMS-345541 targets inhibitor of kinase and induces apoptosis in melanoma: involvement of nuclear factor kB and mitochondria pathways. Clin Cancer Res. 2006;12(3 Pt 1):950-960.Google Scholar
Bonizzi, G, Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25(6):280-288.CrossRefGoogle ScholarPubMed
Luo, JL, Kamata, H, Karin, M. IKK/NF- kB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest. 2005;115(10):2625-2632.CrossRefGoogle Scholar
Kucharczak, J, Simmons, MJ, Fan, Y, et al. To be, or not to be: NF- kB is the answer role of Rel /NF- in the regulation of apoptosis. Oncogene. 2003;22(56):8961-8982.10.1038/sj.onc.1207230CrossRefGoogle ScholarPubMed
Nicotra, L, Loram, LC, Watkins, LR, et al. Toll-like receptors in chronic pain. Exp Neurol. 2012;234(2):316-329.10.1016/j.expneurol.2011.09.038CrossRefGoogle ScholarPubMed
Hsu, DZ, Chen, SJ, Chu, PY, et al. Therapeutic effects of sesame oil on monosodium urate crystal induced acute inflammatory response in rats. Springer Plus. 2013;2(1):659.CrossRefGoogle ScholarPubMed
Li, R, Cai, J, Ou, Z, et al. Effect of “Tong Fengkang II Grain” on TLRs/MyD88 Pathway of Acute Gout Arthritis. Lishizhen Medicine and Materia Medica Research. 2015;26(1):37-39.Google Scholar
Wang, Y, Zhang, X, Feng, X, et al. Expression of Toll-like receptor 4 in lungs of immune-suppressed rat with Acinetobacter baumannii infection. Exp Ther Med. 2016;12(4):2599-2605.CrossRefGoogle ScholarPubMed
Lee, KY. Pneumonia, acute respiratory distress syndrome and early immune-modulator therapy. Int J Mol Sci. 2017;18(2):388.10.3390/ijms18020388CrossRefGoogle ScholarPubMed